Global Epidermolysis Bullosa Therapeutics Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Epidermolysis Bullosa Therapeutics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Epidermolysis Bullosa Therapeutics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Epidermolysis Bullosa Therapeutics by Country/Region, 2017, 2022 & 2028

2.2 Epidermolysis Bullosa Therapeutics Segment by Type

2.2.1 EB-201

2.2.2 FCX-007

2.2.3 ICX-RHY

2.2.4 INM-750

2.2.5 Others

2.3 Epidermolysis Bullosa Therapeutics Sales by Type

2.3.1 Global Epidermolysis Bullosa Therapeutics Sales Market Share by Type (2017-2022)

2.3.2 Global Epidermolysis Bullosa Therapeutics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Epidermolysis Bullosa Therapeutics Sale Price by Type (2017-2022)

2.4 Epidermolysis Bullosa Therapeutics Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Epidermolysis Bullosa Therapeutics Sales by Application

2.5.1 Global Epidermolysis Bullosa Therapeutics Sale Market Share by Application (2017-2022)

2.5.2 Global Epidermolysis Bullosa Therapeutics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Epidermolysis Bullosa Therapeutics Sale Price by Application (2017-2022)

3 Global Epidermolysis Bullosa Therapeutics by Company

3.1 Global Epidermolysis Bullosa Therapeutics Breakdown Data by Company

3.1.1 Global Epidermolysis Bullosa Therapeutics Annual Sales by Company (2020-2022)

3.1.2 Global Epidermolysis Bullosa Therapeutics Sales Market Share by Company (2020-2022)

3.2 Global Epidermolysis Bullosa Therapeutics Annual Revenue by Company (2020-2022)

3.2.1 Global Epidermolysis Bullosa Therapeutics Revenue by Company (2020-2022)

3.2.2 Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Company (2020-2022)

3.3 Global Epidermolysis Bullosa Therapeutics Sale Price by Company

3.4 Key Manufacturers Epidermolysis Bullosa Therapeutics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Epidermolysis Bullosa Therapeutics Product Location Distribution

3.4.2 Players Epidermolysis Bullosa Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Epidermolysis Bullosa Therapeutics by Geographic Region

4.1 World Historic Epidermolysis Bullosa Therapeutics Market Size by Geographic Region (2017-2022)

4.1.1 Global Epidermolysis Bullosa Therapeutics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Epidermolysis Bullosa Therapeutics Annual Revenue by Geographic Region

4.2 World Historic Epidermolysis Bullosa Therapeutics Market Size by Country/Region (2017-2022)

4.2.1 Global Epidermolysis Bullosa Therapeutics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Epidermolysis Bullosa Therapeutics Annual Revenue by Country/Region

4.3 Americas Epidermolysis Bullosa Therapeutics Sales Growth

4.4 APAC Epidermolysis Bullosa Therapeutics Sales Growth

4.5 Europe Epidermolysis Bullosa Therapeutics Sales Growth

4.6 Middle East & Africa Epidermolysis Bullosa Therapeutics Sales Growth

5 Americas

5.1 Americas Epidermolysis Bullosa Therapeutics Sales by Country

5.1.1 Americas Epidermolysis Bullosa Therapeutics Sales by Country (2017-2022)

5.1.2 Americas Epidermolysis Bullosa Therapeutics Revenue by Country (2017-2022)

5.2 Americas Epidermolysis Bullosa Therapeutics Sales by Type

5.3 Americas Epidermolysis Bullosa Therapeutics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Epidermolysis Bullosa Therapeutics Sales by Region

6.1.1 APAC Epidermolysis Bullosa Therapeutics Sales by Region (2017-2022)

6.1.2 APAC Epidermolysis Bullosa Therapeutics Revenue by Region (2017-2022)

6.2 APAC Epidermolysis Bullosa Therapeutics Sales by Type

6.3 APAC Epidermolysis Bullosa Therapeutics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Epidermolysis Bullosa Therapeutics by Country

7.1.1 Europe Epidermolysis Bullosa Therapeutics Sales by Country (2017-2022)

7.1.2 Europe Epidermolysis Bullosa Therapeutics Revenue by Country (2017-2022)

7.2 Europe Epidermolysis Bullosa Therapeutics Sales by Type

7.3 Europe Epidermolysis Bullosa Therapeutics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Epidermolysis Bullosa Therapeutics by Country

8.1.1 Middle East & Africa Epidermolysis Bullosa Therapeutics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue by Country (2017-2022)

8.2 Middle East & Africa Epidermolysis Bullosa Therapeutics Sales by Type

8.3 Middle East & Africa Epidermolysis Bullosa Therapeutics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Epidermolysis Bullosa Therapeutics

10.3 Manufacturing Process Analysis of Epidermolysis Bullosa Therapeutics

10.4 Industry Chain Structure of Epidermolysis Bullosa Therapeutics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Epidermolysis Bullosa Therapeutics Distributors

11.3 Epidermolysis Bullosa Therapeutics Customer

12 World Forecast Review for Epidermolysis Bullosa Therapeutics by Geographic Region

12.1 Global Epidermolysis Bullosa Therapeutics Market Size Forecast by Region

12.1.1 Global Epidermolysis Bullosa Therapeutics Forecast by Region (2023-2028)

12.1.2 Global Epidermolysis Bullosa Therapeutics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Epidermolysis Bullosa Therapeutics Forecast by Type

12.7 Global Epidermolysis Bullosa Therapeutics Forecast by Application

13 Key Players Analysis

13.1 Birken AG

13.1.1 Birken AG Company Information

13.1.2 Birken AG Epidermolysis Bullosa Therapeutics Product Offered

13.1.3 Birken AG Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Birken AG Main Business Overview

13.1.5 Birken AG Latest Developments

13.2 Fibrocell Science, Inc.

13.2.1 Fibrocell Science, Inc. Company Information

13.2.2 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Product Offered

13.2.3 Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Fibrocell Science, Inc. Main Business Overview

13.2.5 Fibrocell Science, Inc. Latest Developments

13.3 GlaxoSmithKline Plc

13.3.1 GlaxoSmithKline Plc Company Information

13.3.2 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Product Offered

13.3.3 GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Plc Main Business Overview

13.3.5 GlaxoSmithKline Plc Latest Developments

13.4 InMed Pharmaceuticals Inc.

13.4.1 InMed Pharmaceuticals Inc. Company Information

13.4.2 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Product Offered

13.4.3 InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 InMed Pharmaceuticals Inc. Main Business Overview

13.4.5 InMed Pharmaceuticals Inc. Latest Developments

13.5 Karus Therapeutics Limited

13.5.1 Karus Therapeutics Limited Company Information

13.5.2 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Product Offered

13.5.3 Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Karus Therapeutics Limited Main Business Overview

13.5.5 Karus Therapeutics Limited Latest Developments

13.6 ProQR Therapeutics N.V.

13.6.1 ProQR Therapeutics N.V. Company Information

13.6.2 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Product Offered

13.6.3 ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 ProQR Therapeutics N.V. Main Business Overview

13.6.5 ProQR Therapeutics N.V. Latest Developments

13.7 RegeneRx Biopharmaceuticals, Inc.

13.7.1 RegeneRx Biopharmaceuticals, Inc. Company Information

13.7.2 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Product Offered

13.7.3 RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 RegeneRx Biopharmaceuticals, Inc. Main Business Overview

13.7.5 RegeneRx Biopharmaceuticals, Inc. Latest Developments

13.8 Scioderm, Inc.

13.8.1 Scioderm, Inc. Company Information

13.8.2 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Product Offered

13.8.3 Scioderm, Inc. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Scioderm, Inc. Main Business Overview

13.8.5 Scioderm, Inc. Latest Developments

13.9 Stratatech Corporation

13.9.1 Stratatech Corporation Company Information

13.9.2 Stratatech Corporation Epidermolysis Bullosa Therapeutics Product Offered

13.9.3 Stratatech Corporation Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Stratatech Corporation Main Business Overview

13.9.5 Stratatech Corporation Latest Developments

13.10 TWi Pharmaceuticals, Inc.

13.10.1 TWi Pharmaceuticals, Inc. Company Information

13.10.2 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Product Offered

13.10.3 TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 TWi Pharmaceuticals, Inc. Main Business Overview

13.10.5 TWi Pharmaceuticals, Inc. Latest Developments

13.11 WAVE Life Sciences Ltd.

13.11.1 WAVE Life Sciences Ltd. Company Information

13.11.2 WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Product Offered

13.11.3 WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 WAVE Life Sciences Ltd. Main Business Overview

13.11.5 WAVE Life Sciences Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Epidermolysis Bullosa Therapeutics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Epidermolysis Bullosa Therapeutics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of EB-201

Table 4. Major Players of FCX-007

Table 5. Major Players of ICX-RHY

Table 6. Major Players of INM-750

Table 7. Major Players of Others

Table 8. Global Epidermolysis Bullosa Therapeutics Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Type (2017-2022)

Table 10. Global Epidermolysis Bullosa Therapeutics Revenue by Type (2017-2022) & ($ million)

Table 11. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Type (2017-2022)

Table 12. Global Epidermolysis Bullosa Therapeutics Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Epidermolysis Bullosa Therapeutics Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Application (2017-2022)

Table 15. Global Epidermolysis Bullosa Therapeutics Revenue by Application (2017-2022)

Table 16. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Application (2017-2022)

Table 17. Global Epidermolysis Bullosa Therapeutics Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Epidermolysis Bullosa Therapeutics Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Company (2020-2022)

Table 20. Global Epidermolysis Bullosa Therapeutics Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Company (2020-2022)

Table 22. Global Epidermolysis Bullosa Therapeutics Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Epidermolysis Bullosa Therapeutics Producing Area Distribution and Sales Area

Table 24. Players Epidermolysis Bullosa Therapeutics Products Offered

Table 25. Epidermolysis Bullosa Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Epidermolysis Bullosa Therapeutics Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Epidermolysis Bullosa Therapeutics Sales Market Share Geographic Region (2017-2022)

Table 30. Global Epidermolysis Bullosa Therapeutics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Epidermolysis Bullosa Therapeutics Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Country/Region (2017-2022)

Table 34. Global Epidermolysis Bullosa Therapeutics Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Epidermolysis Bullosa Therapeutics Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Epidermolysis Bullosa Therapeutics Sales Market Share by Country (2017-2022)

Table 38. Americas Epidermolysis Bullosa Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Epidermolysis Bullosa Therapeutics Revenue Market Share by Country (2017-2022)

Table 40. Americas Epidermolysis Bullosa Therapeutics Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Epidermolysis Bullosa Therapeutics Sales Market Share by Type (2017-2022)

Table 42. Americas Epidermolysis Bullosa Therapeutics Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Epidermolysis Bullosa Therapeutics Sales Market Share by Application (2017-2022)

Table 44. APAC Epidermolysis Bullosa Therapeutics Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Epidermolysis Bullosa Therapeutics Sales Market Share by Region (2017-2022)

Table 46. APAC Epidermolysis Bullosa Therapeutics Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Epidermolysis Bullosa Therapeutics Revenue Market Share by Region (2017-2022)

Table 48. APAC Epidermolysis Bullosa Therapeutics Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Epidermolysis Bullosa Therapeutics Sales Market Share by Type (2017-2022)

Table 50. APAC Epidermolysis Bullosa Therapeutics Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Epidermolysis Bullosa Therapeutics Sales Market Share by Application (2017-2022)

Table 52. Europe Epidermolysis Bullosa Therapeutics Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Epidermolysis Bullosa Therapeutics Sales Market Share by Country (2017-2022)

Table 54. Europe Epidermolysis Bullosa Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Epidermolysis Bullosa Therapeutics Revenue Market Share by Country (2017-2022)

Table 56. Europe Epidermolysis Bullosa Therapeutics Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Epidermolysis Bullosa Therapeutics Sales Market Share by Type (2017-2022)

Table 58. Europe Epidermolysis Bullosa Therapeutics Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Epidermolysis Bullosa Therapeutics Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Epidermolysis Bullosa Therapeutics

Table 69. Key Market Challenges & Risks of Epidermolysis Bullosa Therapeutics

Table 70. Key Industry Trends of Epidermolysis Bullosa Therapeutics

Table 71. Epidermolysis Bullosa Therapeutics Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Epidermolysis Bullosa Therapeutics Distributors List

Table 74. Epidermolysis Bullosa Therapeutics Customer List

Table 75. Global Epidermolysis Bullosa Therapeutics Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Epidermolysis Bullosa Therapeutics Sales Market Forecast by Region

Table 77. Global Epidermolysis Bullosa Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Epidermolysis Bullosa Therapeutics Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Epidermolysis Bullosa Therapeutics Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Epidermolysis Bullosa Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Epidermolysis Bullosa Therapeutics Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Epidermolysis Bullosa Therapeutics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Epidermolysis Bullosa Therapeutics Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Epidermolysis Bullosa Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Epidermolysis Bullosa Therapeutics Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Epidermolysis Bullosa Therapeutics Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Epidermolysis Bullosa Therapeutics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Epidermolysis Bullosa Therapeutics Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Epidermolysis Bullosa Therapeutics Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Epidermolysis Bullosa Therapeutics Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Epidermolysis Bullosa Therapeutics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Epidermolysis Bullosa Therapeutics Revenue Market Share Forecast by Application (2023-2028)

Table 95. Birken AG Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 96. Birken AG Epidermolysis Bullosa Therapeutics Product Offered

Table 97. Birken AG Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Birken AG Main Business

Table 99. Birken AG Latest Developments

Table 100. Fibrocell Science, Inc. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 101. Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Product Offered

Table 102. Fibrocell Science, Inc. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Fibrocell Science, Inc. Main Business

Table 104. Fibrocell Science, Inc. Latest Developments

Table 105. GlaxoSmithKline Plc Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 106. GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Product Offered

Table 107. GlaxoSmithKline Plc Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. GlaxoSmithKline Plc Main Business

Table 109. GlaxoSmithKline Plc Latest Developments

Table 110. InMed Pharmaceuticals Inc. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 111. InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Product Offered

Table 112. InMed Pharmaceuticals Inc. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. InMed Pharmaceuticals Inc. Main Business

Table 114. InMed Pharmaceuticals Inc. Latest Developments

Table 115. Karus Therapeutics Limited Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 116. Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Product Offered

Table 117. Karus Therapeutics Limited Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Karus Therapeutics Limited Main Business

Table 119. Karus Therapeutics Limited Latest Developments

Table 120. ProQR Therapeutics N.V. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 121. ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Product Offered

Table 122. ProQR Therapeutics N.V. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. ProQR Therapeutics N.V. Main Business

Table 124. ProQR Therapeutics N.V. Latest Developments

Table 125. RegeneRx Biopharmaceuticals, Inc. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 126. RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Product Offered

Table 127. RegeneRx Biopharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. RegeneRx Biopharmaceuticals, Inc. Main Business

Table 129. RegeneRx Biopharmaceuticals, Inc. Latest Developments

Table 130. Scioderm, Inc. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 131. Scioderm, Inc. Epidermolysis Bullosa Therapeutics Product Offered

Table 132. Scioderm, Inc. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Scioderm, Inc. Main Business

Table 134. Scioderm, Inc. Latest Developments

Table 135. Stratatech Corporation Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 136. Stratatech Corporation Epidermolysis Bullosa Therapeutics Product Offered

Table 137. Stratatech Corporation Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Stratatech Corporation Main Business

Table 139. Stratatech Corporation Latest Developments

Table 140. TWi Pharmaceuticals, Inc. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 141. TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Product Offered

Table 142. TWi Pharmaceuticals, Inc. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. TWi Pharmaceuticals, Inc. Main Business

Table 144. TWi Pharmaceuticals, Inc. Latest Developments

Table 145. WAVE Life Sciences Ltd. Basic Information, Epidermolysis Bullosa Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 146. WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Product Offered

Table 147. WAVE Life Sciences Ltd. Epidermolysis Bullosa Therapeutics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. WAVE Life Sciences Ltd. Main Business

Table 149. WAVE Life Sciences Ltd. Latest Developments

List of Figures

Figure 1. Picture of Epidermolysis Bullosa Therapeutics

Figure 2. Epidermolysis Bullosa Therapeutics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Epidermolysis Bullosa Therapeutics Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Epidermolysis Bullosa Therapeutics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Epidermolysis Bullosa Therapeutics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of EB-201

Figure 10. Product Picture of FCX-007

Figure 11. Product Picture of ICX-RHY

Figure 12. Product Picture of INM-750

Figure 13. Product Picture of Others

Figure 14. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Type in 2021

Figure 15. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Type (2017-2022)

Figure 16. Epidermolysis Bullosa Therapeutics Consumed in Clinic

Figure 17. Global Epidermolysis Bullosa Therapeutics Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Epidermolysis Bullosa Therapeutics Consumed in Hospital

Figure 19. Global Epidermolysis Bullosa Therapeutics Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Epidermolysis Bullosa Therapeutics Consumed in Others

Figure 21. Global Epidermolysis Bullosa Therapeutics Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Application (2017-2022)

Figure 23. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Application in 2021

Figure 24. Epidermolysis Bullosa Therapeutics Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Company in 2021

Figure 26. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Geographic Region in 2021

Figure 28. Global Epidermolysis Bullosa Therapeutics Sales Market Share by Region (2017-2022)

Figure 29. Global Epidermolysis Bullosa Therapeutics Revenue Market Share by Country/Region in 2021

Figure 30. Americas Epidermolysis Bullosa Therapeutics Sales 2017-2022 (K Pcs)

Figure 31. Americas Epidermolysis Bullosa Therapeutics Revenue 2017-2022 ($ Millions)

Figure 32. APAC Epidermolysis Bullosa Therapeutics Sales 2017-2022 (K Pcs)

Figure 33. APAC Epidermolysis Bullosa Therapeutics Revenue 2017-2022 ($ Millions)

Figure 34. Europe Epidermolysis Bullosa Therapeutics Sales 2017-2022 (K Pcs)

Figure 35. Europe Epidermolysis Bullosa Therapeutics Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue 2017-2022 ($ Millions)

Figure 38. Americas Epidermolysis Bullosa Therapeutics Sales Market Share by Country in 2021

Figure 39. Americas Epidermolysis Bullosa Therapeutics Revenue Market Share by Country in 2021

Figure 40. United States Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Epidermolysis Bullosa Therapeutics Sales Market Share by Region in 2021

Figure 45. APAC Epidermolysis Bullosa Therapeutics Revenue Market Share by Regions in 2021

Figure 46. China Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Epidermolysis Bullosa Therapeutics Sales Market Share by Country in 2021

Figure 53. Europe Epidermolysis Bullosa Therapeutics Revenue Market Share by Country in 2021

Figure 54. Germany Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Epidermolysis Bullosa Therapeutics Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Epidermolysis Bullosa Therapeutics Revenue Market Share by Country in 2021

Figure 61. Egypt Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Epidermolysis Bullosa Therapeutics Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Epidermolysis Bullosa Therapeutics in 2021

Figure 67. Manufacturing Process Analysis of Epidermolysis Bullosa Therapeutics

Figure 68. Industry Chain Structure of Epidermolysis Bullosa Therapeutics

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles